9th Cir. Panel Upholds Dismissal of Medtronic Drug-Infusion Pump Action

  • Memorandum

SAN FRANCISCO — A federal appeals panel has upheld dismissal of state law claims in a Medtronic drug-infusion pump case, finding the manufacturer complied with federal law by filing adverse event reports with the Food and Drug Administration.

In a Jan. 28 opinion, the 9th Circuit U.S. Court of Appeals panel further found the plaintiff failed to adequately specify the nature of the device’s alleged defects and did not demonstrate a genuine dispute of material fact over whether she justifiably relied upon any of Medtronic’s statements.

Rebeca Lawrence sued Medtronic in the U.S. District Court for the Central District of …


HarrisMartin's Midwest Asbestos Litigation Conference

September 21, 2021 - St. Louis, MO
Four Seasons Hotel, St. Louis